4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank38
3Y CAGR+4.8%
5Y CAGR-26.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+4.8%/yr
vs -13.1%/yr prior
5Y CAGR
-26.3%/yr
Recent acceleration
Acceleration
+17.9pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $60.24M | -59.7% |
| 2024 | $149.34M | -40.1% |
| 2023 | $249.11M | +375.8% |
| 2022 | $52.35M | -65.8% |
| 2021 | $153.00M | -44.7% |
| 2020 | $276.73M | +457.3% |
| 2019 | $49.65M | -45.9% |
| 2018 | $91.76M | +284.7% |
| 2017 | $23.85M | - |